Glimepiride

Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3

A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria

Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Type 2 Diabetes

Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride

Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data

Replication of the GRADE Diabetes Trial in Healthcare Claims Data

Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes

Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 Diabetes

The Effects of Glimepiride in Patients With Type 2 Diabetes and Chronic Heart Failure

Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects

Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass

The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes

Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin

SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD

Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy

Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes

Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination

Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)

Effect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 Diabetes